2023
DOI: 10.1016/j.clon.2022.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Neoadjuvant Therapy on the Functional Outcome of Patients With Rectal Cancer: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 91 publications
0
5
0
Order By: Relevance
“…However, neoadjuvant CCRT can also have side effects that may contribute to the development of LARS 33 . For example, radiation therapy can damage the nerves and muscles in the pelvic region, resulting in bowel dysfunction that might present as diarrhea, constipation, or rectal bleeding 34 . Chemotherapy can also cause changes in bowel function and may increase the risk of diarrhea, a common symptom of LARS 35 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, neoadjuvant CCRT can also have side effects that may contribute to the development of LARS 33 . For example, radiation therapy can damage the nerves and muscles in the pelvic region, resulting in bowel dysfunction that might present as diarrhea, constipation, or rectal bleeding 34 . Chemotherapy can also cause changes in bowel function and may increase the risk of diarrhea, a common symptom of LARS 35 .…”
Section: Discussionmentioning
confidence: 99%
“…33 For example, radiation therapy can damage the nerves and muscles in the pelvic region, resulting in bowel dysfunction that might present as diarrhea, constipation, or rectal bleeding. 34 Chemotherapy can also cause changes in bowel function and may increase the risk of diarrhea, a common symptom of LARS. 35 Battersby et al 36 predicted bowel dysfunction severity before anterior resection using the nomogram method with various preoperative covariates, including age, tumor height, total versus partial mesorectal excision, stoma, and preoperative radiotherapy.…”
Section: Lars Syndromementioning
confidence: 99%
“…Li et al conducted a meta-analysis in 2022, including 33 studies and involving 17,917 patients. The study concluded that neoadjuvant therapy emerged as an independent risk factor for the significant development of major LARS, with an odds ratio of 3.09 ( p < 0.001) [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…Tabchouri et al 29 reported that patients with rectal cancer receiving neoadjuvant CCRT had higher incidence rates of postoperative anastomotic leakage and sepsis. In addition, neoadjuvant radiation has been increasingly associated with postoperative bowel dysfunction, including low anterior resection syndrome 30 . Some postoperative patients with poor sphincter function may have a higher risk of PS formation.…”
Section: Discussionmentioning
confidence: 99%